Validation of a model to predict all-cause in-hospital mortality in vascular surgical patients

Cardiovasc J Afr. 2008 Nov-Dec;19(6):303-8.

Abstract

Objective: To develop and validate a pre- and postoperative model of all-cause in-hospital mortality in South African vascular surgical patients.

Methods: We carried out a retrospective cohort study. A multivariate analysis using binary logistic regression was conducted on a derivation cohort using clinical, physiological and surgical data. Interaction and colinearity between covariates were investigated. The models were validated using the Homer-Lemeshow goodness-of-fit test.

Results: Independent predictors of in-hospital mortality in the pre-operative model were: (1) age (per one-year increase) [odds ratio (OR) 1.03, 95% confidence interval (CI) 1.0-1.06), (2) creatinine > 180 micromol.l(-1) (OR 6.43, 95% CI: 3.482-11.86), (3) chronic beta-blocker therapy (OR 2.48, 95% CI: 1.38-4.48), and (4) absence of chronic statin therapy (OR 2.81, 95% CI: 1.15-6.83). Independent predictors of mortality in the postoperative model were: (1) age (per one-year increase) (OR 1.05, 95% CI: 1.02-1.09), (2) creatinine > 180 micromol.l(-1) (OR 5.08, 95% CI: 2.50-10.31), (3) surgery out of hours without statin therapy (OR 8.27, 95% CI: 3.36-20.38), (4) mean daily postoperative heart rate (HR) (OR 1.02, 95% CI: 1.0-1.04), (5) mean daily postoperative HR in the presence of a mean daily systolic blood pressure of less than 100 beats per minute or above 179 mmHg (OR 1.02, 95% CI: 1.01-1.03) and (6) mean daily postoperative HR associated with withdrawal of chronic beta-blockade (OR 1.02, 95% CI: 1.01-1.03). Both models were validated.

Conclusion: The pre-operative model may predict the risk of in-hospital mortality associated with vascular surgery. The postoperative model may identify patients whose risk increases as a result of surgical or physiological factors.

Publication types

  • Validation Study

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Age Factors
  • Aged
  • Blood Pressure
  • Cardiovascular Diseases / mortality*
  • Cardiovascular Diseases / physiopathology
  • Cardiovascular Diseases / surgery*
  • Cohort Studies
  • Creatinine / blood
  • Female
  • Heart Rate
  • Hospital Mortality
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Logistic Models
  • Male
  • Middle Aged
  • Models, Cardiovascular*
  • Models, Statistical*
  • Multivariate Analysis
  • Postoperative Period
  • Predictive Value of Tests
  • Preoperative Care
  • Reproducibility of Results
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • South Africa
  • Vascular Surgical Procedures / mortality*

Substances

  • Adrenergic beta-Antagonists
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Creatinine